Antibody seroconversion in asymptomatic andsymptomatic patients infected with severe acuterespiratory syndrome coronavirus 2 (SARS-CoV-2)

Antibody seroconversion in asymptomatic andsymptomatic patients infected with severe acuterespiratory syndrome coronavirus 2 (SARS-CoV-2)

<strong>Objectives</strong> Asymptomatic and symptomatic patients may transmit severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), but their clinical features and immune responses remain largely unclear. We aimed to characterise the clinical features and immune responses of asy...

Полное описание

Библиографические подробности
Главные авторы:	Jiang, C, Wang, Y, Hu, M, Wen, L, Wen, C, Zhu, W, Tai, S, Jiang, Z, Xiao, K, Faria, NR, De Clercq, E, Xu, J, Li, G
Формат:	Journal article
Язык:	English
Опубликовано:	Wiley 2020

Схожие документы

Antibody seroconversion in asymptomatic and symptomatic patients infected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
по: Chuanhao Jiang, и др.
Опубликовано: (2020-01-01)

Epidemiological feature, viral shedding, and antibody seroconversion among asymptomatic SARS-CoV-2 carriers and symptomatic/presymptomatic COVID-19 patients
по: Yi Chen, и др.
Опубликовано: (2021-07-01)

Seroconversion in COVID-19 Infection and Comparison of Antibody Responses in Symptomatic Versus Asymptomatic Individuals
по: S. Thasneem Banu, и др.
Опубликовано: (2023-03-01)

Seroconversion and Abundance of IgG Antibodies against S1-RBD of SARS-CoV-2 and Neutralizing Activity in the Chilean Population
по: R. González-Stegmaier, и др.
Опубликовано: (2021-01-01)

IgG Seroconversion and Pathophysiology in Severe Acute Respiratory Syndrome Coronavirus 2 Infection
по: Henry M. Staines, и др.
Опубликовано: (2021-01-01)

Evaluating SARS-CoV-2 Seroconversion Following Relieve of Confinement Measures
по: Juliana Gonçalves, и др.
Опубликовано: (2020-12-01)

Exposed seronegative: cellular immune responses to SARS-CoV-2 in the absence of seroconversion
по: Jay, C, и др.
Опубликовано: (2023)

Persistence of the SARS-CoV-2 Antibody Response in Asymptomatic Patients in Correctional Facilities
по: Xiaodong Tian, и др.
Опубликовано: (2021-11-01)

Assessment of Seroconversion to SARS-CoV-2 in Health Care Unitunit Personnel
по: A. I. Blokh, и др.
Опубликовано: (2021-11-01)

Evaluación de la seroconversión de anticuerpos contra SARS-COV-2
по: Diego Fernando López Muñoz, и др.
Опубликовано: (2022-07-01)

Can vitamin D status influence seroconversion to SARS-COV2 vaccines?
по: Endrit Shahini, и др.
Опубликовано: (2022-12-01)

Seroconversion after Inactive SARS-CoV-2 Vaccination and Obesity: Correspondence
по: Rujittika Mungmunpuntipantip, и др.
Опубликовано: (2022-11-01)

Seroconversion to mRNA SARS-CoV-2 Vaccines in Hematologic Patients
по: Bruno Fattizzo, и др.
Опубликовано: (2022-05-01)

Sensitive detection of SARS-CoV-2 seroconversion by flow cytometry reveals the presence of nucleoprotein-reactive antibodies in unexposed individuals
по: Leire Egia-Mendikute, и др.
Опубликовано: (2021-04-01)

Estimation of the Seroconversion Duration of HIV-1 Antibodies in Individuals With Recent Infection in China
по: Wen-Hua Kong, и др.
Опубликовано: (2019-06-01)

SARS-CoV-2 Seroconversion in an Adult Horse with Direct Contact to a COVID-19 Individual
по: Nicola Pusterla, и др.
Опубликовано: (2022-05-01)

Assessment of Seroconversion to SARS-CoV-2 in a Cohort of Pediatric Kidney Transplant Recipients
по: Corina Nailescu, и др.
Опубликовано: (2020-10-01)

On the caveats of a multiplex test for SARS-CoV-2 to detect seroconversion after infection or vaccination
по: Lorena O. Fernandes-Siqueira, и др.
Опубликовано: (2022-06-01)

Assessment of Diagnostic Specificity of Anti-SARS-CoV-2 Antibody Tests and Their Application for Monitoring of Seroconversion and Stability of Antiviral Antibody Response in Healthcare Workers in Moscow
по: Vera S. Kichatova, и др.
Опубликовано: (2022-02-01)

Assessment of Seroconversion after SARS-CoV-2 Vaccination in Patients with Lung Cancer
по: Ioannis P. Trontzas, и др.
Опубликовано: (2022-04-01)

Corrigendum: Can vitamin D status influence seroconversion to SARS-COV2 vaccines?
по: Endrit Shahini, и др.
Опубликовано: (2023-05-01)

Exposed seronegative: Cellular immune responses to SARS-CoV-2 in the absence of seroconversion
по: Cecilia Jay, и др.
Опубликовано: (2023-01-01)

Dynamics of anti-SARS-CoV-2 seroconversion in individual patients and at the population level
по: Alina Szewczyk-Dąbrowska, и др.
Опубликовано: (2022-01-01)

Dynamics of anti-SARS-CoV-2 seroconversion in individual patients and at the population level.
по: Alina Szewczyk-Dąbrowska, и др.
Опубликовано: (2022-01-01)

Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection
по: Pyoeng Gyun Choe, и др.
Опубликовано: (2021-01-01)

Viral dynamics and antibody responses in people with asymptomatic SARS-CoV-2 infection
по: Zhiwei Sui, и др.
Опубликовано: (2021-05-01)

Comparative analysis of antibodies to SARS-CoV-2 between asymptomatic and convalescent patients
по: Connor J. Dwyer, и др.
Опубликовано: (2021-06-01)

Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths
по: Chih-Cheng Lai, и др.
Опубликовано: (2020-06-01)

Demonstration of Antibodies Against SARS-CoV-2, Neutralizing or Binding, in Seroconversion Panels After mRNA-1273, BNT-162b2, and Ad26.COV2.S Vaccine Administration
по: Francisco Belda BSc, MS, PhD, и др.
Опубликовано: (2023-09-01)

Seroprevalence of SARS-CoV-2 antibodies among oral health care workers with natural seroconversion: a systematic review and meta-analysis
по: Elisabeth Santigli, и др.
Опубликовано: (2025-03-01)

Human leukocyte antigen association with anti-SARS-CoV-2 spike protein antibody seroconversion in renal allograft recipients - An observational study
по: Brijesh Yadav, и др.
Опубликовано: (2022-01-01)

SARS-CoV-2 antibody immunoassays in serial samples reveal earlier seroconversion in acutely ill COVID-19 patients developing ARDS.
по: Marie-Luise Buchholtz, и др.
Опубликовано: (2021-01-01)

Seroconversion dynamic and SARS-CoV-2 seropositivity in unvaccinated population during the first and second outbreaks in Mexico
по: Miguel A. Fernández-Rojas, и др.
Опубликовано: (2022-03-01)

Antibody Responses to SARS-CoV-2 at 8 Weeks Postinfection in Asymptomatic Patients
по: Pyoeng Gyun Choe, и др.
Опубликовано: (2020-10-01)

The incidence of the novel coronavirus SARS-CoV-2 among asymptomatic patients: A systematic review
по: Duaa W. Al-Sadeq, и др.
Опубликовано: (2020-09-01)

Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus
по: Isabel Kinney Ferreira de Miranda Santos, и др.
Опубликовано: (2020-08-01)

Life course exposures continually shape antibody profiles and risk of seroconversion to influenza.
по: Bingyi Yang, и др.
Опубликовано: (2020-07-01)

Unclear but present danger: An asymptomatic SARS-CoV-2 carrier
по: Xuejing Yu, и др.
Опубликовано: (2020-12-01)

Pre-Omicron seroprevalence, seroconversion, and seroreversion of infection-induced SARS-CoV-2 antibodies among a cohort of children and teenagers in Montréal, Canada
по: Kate Zinszer, и др.
Опубликовано: (2023-06-01)

SARS-CoV-2 Seroconversion in Response to Infection and Vaccination: a Time Series Local Study in Brazil
по: Luciano F. Huergo, и др.
Опубликовано: (2022-08-01)